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S U M M A R Y
A 6-year-old boy from India developed an atypical form of rabies following a stray dog bite and as a
consequence of not receiving the standard World Health Organization recommended post-exposure
prophylaxis for category III wounds. Serial rising rabies virus neutralizing antibody titres in serum and
cerebrospinal ﬂuid by rapid ﬂuorescent focus inhibition test helped conﬁrm the diagnosis of rabies. The
child has survived for 4 months since the onset of illness, albeit with neurological sequelae.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Rabies is an almost invariably fatal disease that can present as
the classical furious form or as paralytic rabies. The cardinal
features of furious rabies, namely ﬂuctuating consciousness,
hydrophobia/aerophobia, inspiratory spasms, and signs of auto-
nomic dysfunction, are seen in most patients with this form of the
disease. Conversely, paralytic rabies presents as rapidly progres-
sing lower motor neuron ascending weakness with only motor
disturbance, and consciousness may be preserved right until the
pre-terminal phase.1 The average interval from clinical disease
onset to death has been reported to be 5.7 days in furious rabies
and 11 days in paralytic rabies.2
Approximately 60 000 people die from rabies worldwide each
year, with about 20 000 human deaths occurring in India alone.3,4
Many of the dog bite victims do not receive appropriate post-
exposure prophylaxis, and the use of rabies immunoglobulin in
patients presenting with category III exposure is abysmally low
(2.1%).5* Corresponding author. Tel.: +91-80-26995129; fax: +91-80-26564830.
E-mail address: mshampur@gmail.com (S.N. Madhusudana).
http://dx.doi.org/10.1016/j.ijid.2015.05.005
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).The rare case of a child who developed an atypical form of rabies
despite receiving rabies post-exposure prophylaxis is reported
herein; the patient has survived for 4 months since the onset of
illness, albeit with neurological sequelae.
2. Case report
A 6-year-old boy from a village in western India was bitten by a
stray dog, sustaining category III wounds on his back and the right
side of his neck. His parents took him immediately to the local
primary health centre where the child’s wounds were washed
‘brieﬂy’ with running tap water. Within the next 6 h the child had
received equine rabies immunoglobulin (ERIG) at a dose of 40 IU/
kg, half of which was locally inﬁltrated around the neck bite site
and the other half administered intramuscularly in the gluteal
region. The child also simultaneously received the ﬁrst dose of
puriﬁed chick embryo cell (PCEC) rabies vaccine, 0.5 ml intramus-
cularly in the anterolateral area of the thigh muscle. He received
three subsequent doses of the PCEC rabies vaccine on days 3, 7, and
14 after the bites.
Before the child could receive his ﬁfth dose of vaccine, he
developed mild to moderate fever, a bilateral frontal headache, and
occasional episodes of vomiting (22 days after the dog bite). Onciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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generalized tonic convulsions and was admitted to a local private
hospital. Cerebrospinal ﬂuid (CSF) obtained by lumbar puncture
revealed 82  106 cells/l (all lymphocytes), proteins of 20 mg/dl,
and sugar of 54 mg/dl. A plain computed tomography (CT) scan of
the brain was done and was reported as normal. Over the next
4 days the child continued to develop convulsions and his
sensorium deteriorated progressively. The child no longer recog-
nized his parents or responded to any stimuli, and he had lost his
speech and bladder control. The parents afﬁrmed that the child had
not developed any hydrophobia or aerophobia.
The parents sought treatment for their semi-comatose child
from a district hospital and later from a hospital afﬁliated to a
medical college, where a differential diagnosis of viral encephalitis
or partially treated pyogenic meningitis was considered, and the
child was treated with intravenous acyclovir and ceftriaxone, along
with dexamethasone and mannitol as anti-cerebral oedema
treatment. The convulsions were controlled with intravenous
phenytoin and phenobarbitone. However the child continued to
remain semi-comatose and developed involuntary movements of
both the upper limbs and lips (58 days after the dog bite).
The parents brought their child to our institution (KEM
Hospital, Mumbai) in October 2014 (68 days after the dog bite).
On examination, the child’s vital parameters were normal. He
presented a modiﬁed Glasgow Coma Scale score of 8 (E2 M4 V2).
There was ﬂexion contracture of both ankles. His pupils were equal
and reactive bilaterally. There was no hydrophobia or aerophobia.
Motor system examination revealed hypertonia of all four limbs
with grade 4/5 power. All the deep tendon jerks were brisk
bilaterally. Ankle clonus was present bilaterally. Both plantar
responses were extensor. Dystonic movements of both upper limbs
and oro-mandibular dystonia were noted.
A magnetic resonance imaging (MRI) scan of the brain done on
admission (Figure 1a) was reported by a trainee radiologist as
suggestive of acute disseminated encephalomyelitis (ADEM). The
MRI showed T2/FLAIR hyperintensities in the bilateral basal
ganglia, thalami, and cerebellum, with diffuse involvement of
the deep and periventricular white matter. Mild diffusion
restriction was seen in the gangliocapsular region without any
post contrast enhancement. There was generalized parenchymal
volume loss in the form of dilatation of the ventricular system and
prominence of the sulcal spaces. An MRI of the brainstem and spine
was normal. CSF examination revealed 2  106 lymphocytes/l,
proteins of 46 mg/dl, and sugar of 76 mg/dl (corresponding to
blood sugar of 88 mg/dl). CSF culture was sterile and IgM
antibodies against Japanese encephalitis virus were not detected.Figure 1. Serial axial T2 images of the patient showing worsening of hyperintensities inv
admission, showing T2 hyperintensity in the bilateral basal ganglia, thalami, and deep a
admission, showing subsequent progressive worsening of the lesions with increasing pA diagnosis of post-PCEC vaccine ADEM was made and a
standard course of intravenous methylprednisolone (30 mg/kg/
day once daily for 3 days) followed by oral prednisolone in a
rapidly tapering dose was also given. Since there was no clinical
improvement, standard intravenous immunoglobulin therapy
(0.4 g/kg/day once daily for 5 days) was given. Supportive therapy
in the form of trihexyphenidyl for the dystonia, baclofen and
diazepam for the hypertonia, and sodium valproate as an
anticonvulsant was started. Physiotherapy and splinting of both
lower limbs for contractures was done. Nasogastric tube feeding
was continued.
Since there was no clinical improvement, an MRI scan of the
brain was done on day 18 after admission (Figure 1b). The MRI
showed an increase in the conﬂuent FLAIR and T2 hyperintensities
involving the deep paraventricular as well as subcortical white
matter of both cerebrum and cerebellum. There were persistent T2
hyperintensities involving the bilateral basal ganglia, anterolateral
nuclei of the thalamus, corona radiata, and internal capsule, with
shrinkage of the deep grey structures. Persistent diffusion
restriction was seen in the bilateral gangliocapsular region. On
perfusion study, the entire white matter, deep grey matter, and
cortex were hypoperfused. MRI of the brainstem and spine
continued to show a stable (normal) appearance. Both the MRI
scans of the brain were reviewed by an experienced radiologist and
a revised radiological diagnosis of ‘probable’ rabies encephalitis
was made. A third MRI scan of the brain done at 26 days after
admission (Figure 1c) showed further atrophy of the superﬁcial as
well deep grey matter, with persistent high signal in the supra- and
infratentorial white matter. At this time a radiological diagnosis of
rabies encephalitis was made.
Rabies virus neutralizing antibody (RVNA) was assessed by
rapid ﬂuorescent focus inhibition test (RFFIT), performed at the
Neurovirology Laboratory of the World Health Organization
Collaborating Centre for Reference and Research on Rabies,
NIMHANS, Bangalore, using a method described previously.6 The
titre on day 64 of illness was 262 144 in serum and 4096 in CSF.
Repeat RVNA titres by RFFIT obtained on day 75 of illness were
>262 144 (end-point not determined) in serum and 8192 in CSF.
This conﬁrmed the diagnosis of rabies encephalitis, as the presence
of RVNA in the CSF is considered diagnostic of rabies regardless of
immunization status.7 However, saliva, nuchal skin biopsy, and
CSF samples obtained on day 75 of illness were negative for rabies
viral RNA by real-time TaqMan PCR.
After a month’s stay in our centre, the patient was discharged
after educating the parents about caring for a semi-comatose
patient and providing nasogastric tube feeding. A telephoneolving the bilateral basal ganglia and periventricular and deep white matter. (a) On
nd periventricular white matter. (b) At 18 days after admission. (c) At 26 days after
arenchymal volume loss in the form of dilatation of the ventricular system.
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found the child’s condition to have remained unchanged.
3. Discussion
The present case did not show any typical features of either
furious or paralytic rabies. Based on the initial MRI scan of the
brain, a diagnosis of an extremely rare condition viz. post-PCEC
vaccine ADEM was considered. However, subsequent MRI scans of
the brain showed progressive grey matter changes characteristic of
rabies encephalitis.8
There were serious deviations from the World Health
Organization recommendations, namely (1) ERIG was not
inﬁltrated in the wound on the back, and (2) the dose of PCEC
rabies vaccine administered on days 0, 3, 7, and 14 was half the
recommended dose.3
A recent article has reported that only six patients have
survived rabies encephalitis that has developed after a dog bite
(during the years 1976–2013).9 All six patients had received
incomplete post-exposure prophylaxis treatment for rabies and
none of these patients had exhibited the classical signs of furious
rabies.9 Of these, three patients survived with severe neurological
sequelae, as in the present case.9 Rabies viral RNA could not be
demonstrated in the present case. This could be because of the
presence of high levels of neutralizing antibodies in the patient. An
inverse correlation between the detection of RVNA and the
presence of rabies viral RNA in clinical samples has been reported.
The diagnosis of rabies in the present case was based on the
history of exposure, a compatible clinical syndrome and imaging
ﬁndings, and the detection of RVNA in serum and CSF in high titres
incompatible with vaccination, as seen in most of the reported
survivors.9
This report highlights the lack of awareness, especially in rural
India, of the need for timely, adequate, and appropriate post-
exposure management of human cases exposed to rabies. There is a
need for health authorities to focus more attention on training
rural medical practitioners in prophylactic measures for thisalmost invariably fatal disease, which is almost 100% preventable
with appropriate post-exposure prophylaxis.
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